Lavipharm S.A.
LAVI | AT
Overview
Corporate Details
- ISIN(s):
- GRS246003008
- LEI:
- 213800USC69CRPRGWJ15
- Country:
- Greece
- Address:
- AGIAS MARINAS STR, 19002 PAIANIA
- Website:
- https://lavipharm.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Established in 1911, Lavipharm S.A. is an integrated international healthcare company engaged in the research, development, manufacturing, marketing, and distribution of pharmaceutical and consumer health products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, food supplements, and cosmetics. It focuses on key therapeutic areas such as cardiology, neurology (CNS), urology, oncology, and chronic pain management. Lavipharm leverages proprietary technologies, including advanced drug delivery systems like transdermal patches, to develop innovative and reliable treatment options for healthcare professionals and patients.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Lavipharm S.A..
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-10 09:38 |
Registration Form
Έντυπο παροχής πληροφοριών Κανονισμού (ΕΕ) 2017/1129 (άρθρ. 1 παρ. 5 η’) αναφορ…
|
Greek (modern) | 216.3 KB | |
| 2025-07-09 09:52 |
Share Issue/Capital Change
Έντυπο παροχής πληροφοριών Κανονισμού (ΕΕ) 2017/1129 (άρθρ. 1 παρ. 4 θ΄) αναφορ…
|
Greek (modern) | 205.1 KB | |
| 2025-07-03 18:12 |
Notice of Dividend Amount
ΓΝΩΣΤΟΠΟΙΗΣΗ ΑΠΟΚΟΠΗΣ ΔΙΚΑΙΩΜΑΤΟΣ ΜΕΡΙΣΜΑΤΟΣ / ΠΛΗΡΩΜΗΣ ΜΕΡΙΣΜΑΤΟΣ/ ΠΡΟΜΕΡΙΣΜΑΤ…
|
Greek (modern) | 555.0 KB | |
| 2025-07-03 18:00 |
Post-Annual General Meeting Information
ΔΕΛΤΙΟ ΤΥΠΟΥ ΓΕΝΙΚΗΣ ΣΥΝΕΛΕΥΣΗΣ
|
Greek (modern) | 123.4 KB | |
| 2025-07-03 18:00 |
Post-Annual General Meeting Information
PRESS RELEASE
|
English | 121.3 KB | |
| 2025-07-03 17:35 |
Post-Annual General Meeting Information
ΑΝΑΚΟΙΝΩΣΗ ΕΠΙΤΡΟΠΗΣ ΕΛΕΓΧΟΥ
|
Greek (modern) | 503.0 KB | |
| 2025-07-03 17:17 |
Board/Management Information
ΓΝΩΣΤΟΠΟΙΗΣΗ ΑΛΛΑΓΗΣ ΣΥΝΘΕΣΗΣ ΔΙΟΙΚΗΤΙΚΟΥ ΣΥΜΒΟΥΛΙΟΥ
|
Greek (modern) | 598.1 KB | |
| 2025-07-03 17:05 |
Post-Annual General Meeting Information
ΑΝΑΚΟΙΝΩΣΗ ΓΙΑ ΤΙΣ ΑΠΟΦΑΣΕΙΣ ΓΕΝΙΚΗΣ ΣΥΝΕΛΕΥΣΗΣ
|
Greek (modern) | 195.1 KB | |
| 2025-06-11 16:30 |
Pre-Annual General Meeting Information
ΠΡΟΣΚΛΗΣΗ ΣΕ ΤΑΚΤΙΚΗ ΓΕΝΙΚΗ ΣΥΝΕΛΕΥΣΗ
|
Greek (modern) | 191.0 KB | |
| 2025-05-15 16:19 |
Earnings Release
Βασικά Οικονομικά Μεγέθη A Τριμήνου 2025
|
Greek (modern) | 118.2 KB | |
| 2025-05-15 16:19 |
Earnings Release
Financial Results Q1 2025
|
English | 92.6 KB | |
| 2025-04-24 16:39 |
Investor Presentation
ΑΝΑΚΟΙΝΩΣΗ ΓΙΑ ΕΝΗΜΕΡΩΣΗ ΕΙΣΗΓΜΕΝΗΣ ΠΡΟΣ ΑΝΑΛΥΤΕΣ
|
English | 1.0 MB | |
| 2025-04-24 16:39 |
Regulatory News Service
ΑΝΑΚΟΙΝΩΣΗ ΓΙΑ ΕΝΗΜΕΡΩΣΗ ΕΙΣΗΓΜΕΝΗΣ ΠΡΟΣ ΑΝΑΛΥΤΕΣ
|
Greek (modern) | 116.5 KB | |
| 2025-04-24 16:39 |
Investor Presentation
Annual Analists Briefing
|
English | 61.4 KB | |
| 2025-04-24 16:39 |
Investor Presentation
Annual Analists Briefing
|
English | 1.0 MB |
Automate Your Workflow. Get a real-time feed of all Lavipharm S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Lavipharm S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
